SMarT Minds Dx

Accessible blood test for early detection of Alzheimer's Disease

SMDx is developing an accessible blood-based Alzheimer’s disease diagnostic test for earlier, definitive detection before symptom onset. Proprietary antibodies show equivalence with PET amyloid imaging, at a fraction of the cost.  

Targeting diagnostics and pharmaceutical partners, SMDx Detect™ AD enables scalable testing for diagnosis, preclinical risk determination and treatment monitoring.

Team: Colin Denver

Colin Denver - Founder